[On the evaluation of the effect of a combination of salicylates and prednisolone in rheumatic diseases].
D000208:Acute Disease; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001847:Bone Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy; D010007:Osteochondritis / Q000188:drug therapy*; D010024:Osteoporosis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D010919:Placebos; D010998:Pleurisy / Q000188:drug therapy; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012213:Rheumatic Fever / Q000188:drug therapy; D012459:Salicylates / Q000009:adverse effects / Q000627:therapeutic use*; D013166:Spondylitis / Q000188:drug therapy*
D010406:Penicillins; D010919:Placebos; D012459:Salicylates; D011239:Prednisolone
Zur Beurteilung der Wirkung einer Kombination von Salicylaten und Prednisolon bei rheumatischen Erkrankungen.